As a lawyer specialising in pharmaceutical and IP law, Manja has been advising pharmaceutical and biotechnology companies, medical device manufacturers, and food producers on all matters relating to intellectual property and regulatory questions for many years.

A focus of her practice involves advising clients on contractual projects of a complex and cross-border nature, in particular, research and development cooperations, manufacturing agreements, distribution agreements, licencing agreements, as well as providing advise on all matters relating to transactions.

显示完整简历 隐藏完整简历

最新新闻和观点

商业和消费者合同

The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements

2023年9月21日
In-depth analysis

作者 Dr. Manja Epping 以及 Irina Rebin

点击此处了解更多
酒店与休闲

The EU Commission's new pharmaceutical package: amended legal framework for data protection, marketing protection and market exclusivity

2023年5月31日
In-depth analysis

作者 Dr. Manja Epping 以及 Sherin Sayed

点击此处了解更多
酒店与休闲

The European Commission's pharmaceutical reform package: core objectives and planned changes at a glance

2023年5月10日
Briefing

作者 Dr. Manja Epping 以及 Sherin Sayed

点击此处了解更多
酒店与休闲

The CJEU: The recurring question of the separation of medicinal products and medical devices

2023年4月21日
Briefing

作者 Dr. Manja Epping 以及 Sherin Sayed

点击此处了解更多

与我会面: